EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biospecific Interaction Analysis (BIA) as a Tool for the Design and Development of Gene Transcription Modifiers

R Gambari

Current Medicinal Chemistry-Anti-Cancer Agents · 2001

DOI: 10.2174/1568011013354525 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Medicinal Chemistry-Anti-Cancer Agents, 2001. Verfasst von R Gambari. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Ferrara University, Via Luigi Borsari 46, Ferrara, Italy. gam@unife.it. Hauptthemen laut MEDLINE: Drug Design. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignAnimalsAntineoplastic AgentsAntiviral AgentsBiosensing TechniquesDNA, NeoplasmDNA-Binding ProteinsGene Expression Regulation, NeoplasticHumansMolecular BiologySurface Plasmon ResonanceTranscription, Genetic

Substanzen

Antineoplastic AgentsAntiviral AgentsDNA, NeoplasmDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Ferrara University, Via Luigi Borsari 46, Ferrara, Italy. gam@unife.it

Zitieren

APA

Gambari, R. (2001). Biospecific Interaction Analysis (BIA) as a Tool for the Design and Development of Gene Transcription Modifiers. Current Medicinal Chemistry-Anti-Cancer Agents. https://doi.org/10.2174/1568011013354525

Vancouver

Gambari R. Biospecific Interaction Analysis (BIA) as a Tool for the Design and Development of Gene Transcription Modifiers. Current Medicinal Chemistry-Anti-Cancer Agents. 2001. doi:10.2174/1568011013354525

BibTeX
@article{Gambari2001,
  author = {Gambari, R},
  title = {Biospecific Interaction Analysis (BIA) as a Tool for the Design and Development of Gene Transcription Modifiers},
  journal = {Current Medicinal Chemistry-Anti-Cancer Agents},
  year = {2001},
  doi = {10.2174/1568011013354525}
}
Kostenlos starten →